Meds & supplements › Insulin detemir
Medicine · Insulin Analog
LEVEMIR is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
LEVEMIR is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use LEVEMIR is not recommended for the treatment of diabetic ketoacidosis. LEVEMIR is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
Limitations of Use: Not recommended for the treatment of diabetic ketoacidosis.
Using the vial:
General Information about the safe and effective use of Levemir:
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Manufactured by: Novo Nordisk Inc.
800 Scudders Mill Road
Plainsboro, NJ 08536
U.S. License Number 1261
Revised: 07/2022
For more information go to
www.novotraining.com/levemirflextouch/us02
© 2005-2022 Novo Nordisk
Levemir ®
FlexTouch ®
Read before first use
Instructions For Use
LEVEMIR ® (LEV–uh-mere) FlexPen ®
(insulin detemir)
injection, for subcutaneous use
Please read the following instructions carefully before using your LEVEMIR FlexPen.
Do not share your LEVEMIR FlexPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
LEVEMIR FlexPen is a prefilled disposable, single-patient-use, insulin pen. You can select doses from 1 to 60 units in increments of 1 unit. LEVEMIR FlexPen is designed to be used with NovoFine or NovoFine Plus needles.
People who are blind or have vision problems should not use this Pen without help from a person trained to use the Pen.
Getting ready
Make sure you have the following items:
Preparing your LEVEMIR FlexPen
Wash your hands with soap and water. Before you start to prepare your injection, check the label to make sure that you are taking the right type of insulin. This is especially important if you take more than 1 type of insulin. LEVEMIR should look clear and colorless. Do not use LEVEMIR if it is thick, cloudy, or is colored.
Always use a new needle for each injection to make sure the needle is free of germs (sterile) and to prevent blocked needles. Do not reuse or share your needles with other people. You may give other people a serious infection or get a serious infection from them.
Be careful not to bend or damage the needle before use.
To reduce the risk of needle sticks, never put the inner needle cap back on the needle.
Giving the airshot before each injection
Before each injection, small amounts of air may collect in the cartridge during normal use. To avoid injecting air and to ensure proper dosing:
Selecting your dose
Check and make sure that the dose selector is set at 0.
Giving the injection
Give the injection exactly as shown to you by your healthcare provider. Your healthcare provider should tell you if you need to pinch the skin before injecting. Wipe the skin with an alcohol swab and let the area dry.
LEVEMIR can be injected under the skin (subcutaneously) of your stomach area (abdomen), upper legs (thighs), or upper arms.
Change (rotate) your injection sites within the area you choose for each dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites. Do not use the same injection site for each injection. Do not inject where the skin has pits, is thickened, or has lumps. Do not inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
After the injection
Do not recap the needle. Recapping can lead to a needle stick injury. Remove the needle from the LEVEMIR FlexPen after each injection and dispose of it. This helps to prevent infection, leakage of insulin, and will help to make sure you inject the right dose of insulin.
Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. Do not recycle your used sharps disposal container.
When there is not enough medicine left in your LEVEMIR FlexPen for your prescribed dose, the LEVEMIR FlexPen may be thrown away in your household trash after you have removed the needle.
The LEVEMIR FlexPen prevents the cartridge from being completely emptied. It is designed to deliver 300 units.
The LEVEMIR FlexPen you are using should be thrown away after 42 days, even if it still has insulin left in it.
Keep your LEVEMIR FlexPen and needles out of the reach of children.
Maintenance
For the safe and proper use of your LEVEMIR FlexPen be sure to handle it with care. Avoid dropping your LEVEMIR FlexPen as it may damage it. If you are concerned that your LEVEMIR FlexPen is damaged, use a new one. You can clean the outside of your LEVEMIR FlexPen by wiping it with a damp cloth. Do not soak or wash your LEVEMIR FlexPen as it may damage it. Do not refill your LEVEMIR FlexPen.
Remove the needle from the LEVEMIR FlexPen after each injection. This helps to ensure sterility, prevent leakage of insulin, and will help to make sure you inject the right dose of insulin for future injections.
Be careful when handling used needles to avoid needle sticks and transfer of infectious diseases.
Use the LEVEMIR FlexPen exactly as your healthcare provider tells you to.
Do not share your LEVEMIR FlexPen or needles with other people. You may give other people a serious infection, or get a serious infection from them.
Always use a new needle for each injection.
Novo Nordisk is not responsible for harm due to using this insulin pen with products not recommended by Novo Nordisk.
As a precautionary measure, always carry a spare insulin delivery device in case your LEVEMIR FlexPen is lost or damaged.
Remember to keep the disposable LEVEMIR FlexPen with you. Do not leave it in a car or other location where it can get too hot or too cold.
© 2022 Novo Nordisk
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Manufactured by:
Novo Nordisk Inc.
800 Scudders Mill Road
Plainsboro, NJ 08536
U.S. License Number 1261
Revised: 12/2022
If you clean your injection site with an alcohol swab, let the injection site dry before you inject. Talk with your healthcare provider about how to rotate injection sites and how to give an injection.
Revised: 07/2022
Novo Nordisk ® and LEVEMIR ® are registered trademarks of Novo Nordisk A/S.
PATENT Information: https://www.novonordisk-us.com/products/product-patents.html
© 2005-2022 Novo Nordisk
Manufactured by:
Novo Nordisk Inc.
800 Scudders Mill Road
Plainsboro, NJ 08536
U.S. License Number 1261
INSTRUCTIONS FOR USE
Levemir ® (LEV–uh-mere)
(insulin detemir)
injection, for subcutaneous use
FlexTouch ® Pen
Please read the following instructions carefully before using your Levemir FlexTouch Pen.
Supplies you will need to give your Levemir injection:
Preparing your Levemir FlexTouch Pen:
Priming your Levemir FlexTouch Pen:
Selecting your dose:
Giving your injection:
After your injection:
sofidex [Internet]. Daloreum; c2026. Insulin detemir; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/insulin-detemir
sofidex. (2026, August 3). Insulin detemir. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/insulin-detemir
Insulin detemir. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/insulin-detemir
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.